AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitamik M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Mikayla Life Sciences Pvt. Ltd.

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitamik M 50mg/500mg Tablet

Diabexe Duo 50mg/500mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like kidney disease and vision loss, and may lessen the risk of heart attack or stroke. Diabexe Duo may be used alone or with other diabetes treatments. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is individualized based on your health, blood sugar readings, and other medications. Consuming it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your physician's guidance. Maintaining your prescribed diet and exercise plan is crucial. Lifestyle significantly impacts diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially with concurrent insulin or sulfonylurea use; learn hypoglycemia recognition and management. This medication isn't suitable for everyone. Inform your doctor of any kidney, liver, or heart conditions, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or breastfeeding individuals require medical consultation prior to use. Interactions with other medications are possible; disclose all medications to your doctor for safety. Alcohol should be minimized due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Sitamik M 50mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Sitamik M 50mg/500mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing. Consumption of the Sitamik M 50mg/500mg Tablet should coincide with a meal.

Common Side effects of Sitamik M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitamik M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Sitamik M 50mg/500mg tablets with food.

How Sitamik M 50mg/500mg Tablet works:

Sitagliptin/Metformin 50mg/500mg tablets (Sitamik M) combine two distinct medications to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances insulin utilization, and lessens the liver's glucose output. Metformin, a biguanide, acts by reducing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. This dual-action approach leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Sitamik M 50mg/500mg tablets poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Sitamik M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitamik M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitamik M 50mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. The use of Sitamik M 50mg/500mg tablets is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Patients with liver conditions should likely avoid Sitamik M 50mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitamik M 50mg/500mg Tablet :

Should you forget a Sitamik M 50mg/500mg Tablet dose, take it immediately. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Never take a double dose.

Facts to Know About Sitamik M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Sitamik M 50mg/500mg Tablet

Sitamik M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged Sitamik M 50mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Sitamik M 50mg/500mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitamik M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitamik M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitamik M 50mg/500mg) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding this medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Sitamik M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitamik M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitamik M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitamik M 50mg/500mg Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitamik M 50mg/500mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitamik M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), and urinary issues, potentially impacting mental function. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitamik M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitamik M 50mg/500mg Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitamik M 50mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitamik M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitamik M 50mg/500mg) can cause lactic acidosis, a serious, potentially fatal build-up of lactic acid in the blood (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin immediately and seek urgent medical attention.
Prolonged use of Sitamik M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitamik M 50mg/500mg Tabl...
95
MRP 110
13% off